227 related articles for article (PubMed ID: 16594666)
1. A mechanism-based inactivator for histone demethylase LSD1.
Culhane JC; Szewczuk LM; Liu X; Da G; Marmorstein R; Cole PA
J Am Chem Soc; 2006 Apr; 128(14):4536-7. PubMed ID: 16594666
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.
Yang M; Culhane JC; Szewczuk LM; Jalili P; Ball HL; Machius M; Cole PA; Yu H
Biochemistry; 2007 Jul; 46(27):8058-65. PubMed ID: 17569509
[TBL] [Abstract][Full Text] [Related]
3. trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.
Schmidt DM; McCafferty DG
Biochemistry; 2007 Apr; 46(14):4408-16. PubMed ID: 17367163
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation.
Yang M; Culhane JC; Szewczuk LM; Gocke CB; Brautigam CA; Tomchick DR; Machius M; Cole PA; Yu H
Nat Struct Mol Biol; 2007 Jun; 14(6):535-9. PubMed ID: 17529991
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors.
Culhane JC; Wang D; Yen PM; Cole PA
J Am Chem Soc; 2010 Mar; 132(9):3164-76. PubMed ID: 20148560
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic analysis of a suicide inactivator of histone demethylase LSD1.
Szewczuk LM; Culhane JC; Yang M; Majumdar A; Yu H; Cole PA
Biochemistry; 2007 Jun; 46(23):6892-902. PubMed ID: 17511474
[TBL] [Abstract][Full Text] [Related]
7. New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin.
Forneris F; Battaglioli E; Mattevi A; Binda C
FEBS J; 2009 Aug; 276(16):4304-12. PubMed ID: 19624733
[TBL] [Abstract][Full Text] [Related]
8. Human histone demethylase LSD1 reads the histone code.
Forneris F; Binda C; Vanoni MA; Battaglioli E; Mattevi A
J Biol Chem; 2005 Dec; 280(50):41360-5. PubMed ID: 16223729
[TBL] [Abstract][Full Text] [Related]
9. A spectrophotometric assay for histone deacetylase 8.
Fatkins DG; Zheng W
Anal Biochem; 2008 Jan; 372(1):82-8. PubMed ID: 17920554
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.
Ota Y; Kakizawa T; Itoh Y; Suzuki T
Molecules; 2018 May; 23(5):. PubMed ID: 29734782
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.
Mimasu S; Sengoku T; Fukuzawa S; Umehara T; Yokoyama S
Biochem Biophys Res Commun; 2008 Feb; 366(1):15-22. PubMed ID: 18039463
[TBL] [Abstract][Full Text] [Related]
12. Histone H3 peptides incorporating modified lysine residues as lysine-specific demethylase 1 inhibitors.
Kakizawa T; Ota Y; Itoh Y; Suzuki T
Bioorg Med Chem Lett; 2018 Jan; 28(2):167-169. PubMed ID: 29198865
[TBL] [Abstract][Full Text] [Related]
13. In vitro histone demethylase assay.
Tsukada Y; Nakayama KI
Cold Spring Harb Protoc; 2010 Oct; 2010(10):pdb.prot5512. PubMed ID: 20889709
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterization and biological evaluation of N-protected cyclopropylethylcarbamates as potential histone deacetylase inhibitor.
Jung JC; Moon HI; Oh S
Chem Biol Drug Des; 2008 Dec; 72(6):592-5. PubMed ID: 19090926
[TBL] [Abstract][Full Text] [Related]
15. Histone H3 peptide based LSD1-selective inhibitors.
Kakizawa T; Ota Y; Itoh Y; Tsumoto H; Suzuki T
Bioorg Med Chem Lett; 2015 May; 25(9):1925-8. PubMed ID: 25827526
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization and mapping of the covalently linked FAD cofactor in choline oxidase from Arthrobacter globiformis.
Rand T; Halkier T; Hansen OC
Biochemistry; 2003 Jun; 42(23):7188-94. PubMed ID: 12795615
[TBL] [Abstract][Full Text] [Related]
17. LSD1 Histone Demethylase Assays and Inhibition.
Hayward D; Cole PA
Methods Enzymol; 2016; 573():261-78. PubMed ID: 27372757
[TBL] [Abstract][Full Text] [Related]
18. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.
Binda C; Valente S; Romanenghi M; Pilotto S; Cirilli R; Karytinos A; Ciossani G; Botrugno OA; Forneris F; Tardugno M; Edmondson DE; Minucci S; Mattevi A; Mai A
J Am Chem Soc; 2010 May; 132(19):6827-33. PubMed ID: 20415477
[TBL] [Abstract][Full Text] [Related]
19. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
Codd R; Braich N; Liu J; Soe CZ; Pakchung AA
Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
[TBL] [Abstract][Full Text] [Related]
20. New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations.
Mai A; Valente S; Nebbioso A; Simeoni S; Ragno R; Massa S; Brosch G; De Bellis F; Manzo F; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):235-47. PubMed ID: 18834955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
